目的 通过探讨急性冠脉综合征(acute coronary syndrome,ACS)患者血浆C-反应蛋白(CRP)、基质金属蛋白酶-9(MMP-9)水平的变化,揭示血管炎性反应在ACS发病机制中的作用。方法 选择60例ACS患者作为病变组,其中ST段抬高心肌梗死(ST elevated myocardial infarction,STEMI)20例,非ST段抬高心肌梗死(NSTEMI)13例,不稳定型心绞痛(unstable angina pectoris,UAP)27例;对照组为慢性稳定型心绞痛(stable angina pectoris,SAP)组40例,应用ELISA(酶联免疫吸附双抗夹心法)法检测两组患者的血清CRP、MMP-9水平,进行相关统计学处理。结果 ACS组血浆CRP水平测定结果高于对照组,差异具有统计学意义(P<0.01),AMI组血浆CRP水平测定结果高于UAP组,差异具有统计学意义(P<0.01),且血浆CRP水平高低与ACS的严重程度呈正相关。ACS组血浆MMP-9测定结果高于对照组(P<0.01),AMI组MMP-9水平测定结果高于UAP组,差异具有统计学意义(P<0.01),且MMP-9水平高低与ACS的严重程度呈正相关。结论 血管炎性反应在ACS发病机制中起非常重要的作用,且与疾病的严重程度明显相关;可为ACS的临床干预及病情预后判断提供参考依据。
Abstract
Objective To study the role of vascular Inflammatory reaction in pathogenetic mechanison of acute coronary syndrome (ACS) by detection of the levels of plasma C-reactive protein (CRP) and matrix metalloproteinase-9(MMP-9). Methods CRP and MMP-9 concentrations were measured in 60 patients with acute coronary syndrome (ACS)60,13 patients with non ST elevated myo cardiac infarction (NSTEMI), 20 patients with ST elevated myocardiac infarction (STEMI), 27 patients with unstable angina pectoris, and 40 patients with stable angina pectorts. Compared with normal subjects, the levels of CRP and MMP-9 in ACS patrents were all increased significantly (P<0.01). The levels of CRP and MMP-9 in acute myocardiac infarction were significantly higher than in UAP patients (P<0.01), and they had positive relationship with the severity level of ACS. Results Compared with normal subjects,the levels of CRP and MMP-9 in ACS patients increase significantly,showing that they are the signs of dignosis and estimating severity levels in ACS. At the same time, they provide references to treatment and evalution of ACS.
关键词
血浆C-反应蛋白 /
基质金属蛋白酶-9 /
急性冠脉综合征
Key words
C-reactive protein /
matrix metalloproteinase-9 /
acute coronary syndrome
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 高长斌,张 蕾,石琳琳,等. C反应蛋白与急性冠脉综合征的临床研究[J].中国实验诊断学,2003, 7(3): 217-219.
[2] 王 庆. C-反应蛋白与动脉粥样硬化不稳定性斑块[J].中山大学学报(医学科学版),2004,25(S1):384-386.
[3] 李广平.C反应蛋白与冠状动脉疾病关系的研究进展[J].天津医药,2009,11(37):985.
[4] 万凤福. C反应蛋白与冠心病的相关性分析[J].赣南医学院学报, 2005, 25(6):766-767.
[5] Ridken PM. Clinical application of C-reation protein for cardiovascular disease detection and prevention[J]. Circulation,2003,107:363-369.
[6] 樊 民,李 岚,吴宗贵,等.CD40配体通过诱导型环氧合酶途径诱导单核巨噬细胞分泌基质金属蛋白酶[J].第二军医大学学报, 2006, 27(8): 845-847.
[7] 江 华,李 艳,刘文卫,等.急性冠脉综合征患者血清白介素和基质金属蛋白酶水平检测及临床意义[J].微循环学杂志,2008,18(2):66-67.
[8] 赵然尊.基质金属蛋白酶与冠心病研究新进展[J].心血管病学进展,2005,26(5):501-504.
[9] 王 宁,马 静.基质金属蛋白酶MMP-2、MMP-9及sCD40L对急性冠脉综合征的影响[J].中国社区医师医学专业半月刊,2010,15: 163-164.
[10] 胡小龙,王 宁,任明霞,等. 显微镜下多血管炎一例并文献复习[J].空军医学,2012,28(2):110.
[11] 顾伟明,王育林.急性冠脉综合征患者血清MMP9的变化[J].潍坊医学院学报,2007, 29(4):335-336.